Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Not applicableStudy completedNCT04143230
What this trial is testing

Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool

Who this might be right for
Locally Advanced CancerMetastatic CancerChronic Respiratory Failure+3 more
A.O.U. Città della Salute e della Scienza 660
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03693014
What this trial is testing

Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Who this might be right for
Metastatic CancerMelanoma CancerLung Cancer+3 more
Memorial Sloan Kettering Cancer Center 69
Not applicableStudy completedNCT02527304
What this trial is testing

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Who this might be right for
MelanomaMetastatic Malignant Neoplasm in the SpineRenal Cell Carcinoma+2 more
Albert Einstein College of Medicine 24
Testing effectiveness (Phase 2)Looking for participantsNCT05896839
What this trial is testing

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+10 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Ended earlyNCT00747305
What this trial is testing

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Who this might be right for
Kidney Cancer
Harry Drabkin 17
Testing effectiveness (Phase 2)Ended earlyNCT00467077
What this trial is testing

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
California Cancer Consortium 21
Large-scale testing (Phase 3)Study completedNCT00416429
What this trial is testing

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 456
Early research (Phase 1)Study completedNCT01714765
What this trial is testing

Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cancer
Queen Mary University of London 17
Not applicableNot Yet RecruitingNCT07285538
What this trial is testing

Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer

Who this might be right for
Renal CancerRenal Secondary CancerStereotactic Body Radiotherapy
IRCCS San Raffaele 60
Testing effectiveness (Phase 2)Ended earlyNCT00485563
What this trial is testing

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Endocyte 12
Testing effectiveness (Phase 2)Study completedNCT01566747
What this trial is testing

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Who this might be right for
Renal Cell Carcinoma
Cancer Trials Ireland 43
Large-scale testing (Phase 3)Ended earlyNCT03408652
What this trial is testing

Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 1
Very early researchStudy completedNCT03071328
What this trial is testing

INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell Carcinoma
Duke University 10
Testing effectiveness (Phase 2)Ended earlyNCT02959554
What this trial is testing

Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control

Who this might be right for
Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 49
Not applicableEnded earlyNCT05103722
What this trial is testing

Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Early research (Phase 1)Looking for participantsNCT06399419
What this trial is testing

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more
Osel, Inc. 28
Testing effectiveness (Phase 2)Ended earlyNCT04267120
What this trial is testing

Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine 11
Next Page